I

t’s estimated that more than 13,000 new cases of laryngeal cancer will be diagnosed this year — some of which will cost patients all or part of the voice boxes — but new research using stem cells aims to save their speech by growing new larynges right in the lab.

Dr. David Lott and his colleagues at the Mayo Clinic Center for Regenerative Medicine are leading the charge to change how laryngeal cancer is treated.

Unlock this article by subscribing to STAT Plus today. Try it FREE for 30 days and cancel anytime!

SUBSCRIBE TODAY

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.

Privacy Policy